For the third quarter, Repligen reported revenue of $155 million, reflecting a 10% year-on-year increase. The organization ...

The firm has received a $50 million investment from Texas-based financial aid company Vitrian. This investment includes an option to increase funding up to $65 million. The initial aid will support ...

Contract development and manufacturing organization (CDMO) Celltechna, a part of the Northway Group, has broken ground on a gene therapy center in Vilnius, Lithuania. The €50 million ($54 million) ...

Biopharmaceutical giant GSK announced a site expansion at its Marietta, Pennsylvania site, where it will build a multipurpose manufacturing facility to produce sterile liquid vaccines and other ...

The contract development and manufacturing organization (CDMO) is adding drug delivery technology to its headquarters, while it has broken ground at its 545,000 square-foot Rockford, Illinois site.

Indiana, US-based biopharma bigwig Eli Lilly has doubled its investment to a total of $2 billion at its Limerick, Ireland manufacturing site. The expansion will increase production of biologic active ...

Glucagon-like peptide-1 (GLP-1) drugs for diabetes and weight loss are emerging as the latest blockbuster pharmaceuticals. Like messenger RNA (mRNA) gaining recognition during the pandemic, the ...

The buildout of its $1.5 billion facility will establish the Anglo-Swedish drugmaker’s first manufacturing presence in Singapore. Additionally, it will be AstraZeneca’s first ADC plant to produce the ...

Sanofi will build a €1 billion ($1.1 billion) mAb production facility in Vitry-sur-Seine, while it invests €100 million to bolster capacity at its Le Trait site in Normandy and invests €10 million at ...

Properly scaling from small-scale bioreactors to larger-scale bioreactors for intensified processes is highly dependent on maintaining mixing, oxygenation, nutrient, and process control. To be able to ...